Onivyde pancreatic cancer：Onivyde® improves survival in Phase III pancreatic cancer ...
Onivyde® improves survival in Phase III pancreatic cancer ...
2023年1月23日—Onivyde®(irinotecanliposomeinjection)treatmentregimensignificantlyimprovedsurvivalinaPhaseIIItrialcomparedtonab-paclitaxel ...。其他文章還包含有：「MetastaticPancreaticCancerTreatmentwithONIVYDE®...」、「LiposomalIrinotecan」、「Ipsen'sOnivydeturnsinpositiveresultsinpancreaticcancer」、「Onivyde®regimendemonstratedstatistically...」、「Onivydepegylatedliposomal(previouslyknownasO...
查看更多 離開網站
Metastatic Pancreatic Cancer Treatment with ONIVYDE® ...
https://www.onivyde.com
ONIVYDE is a prescription medicine used to treat pancreatic cancer which has spread to other parts of the body. ONIVYDE can be used in patients who have ...
Liposomal Irinotecan
https://www.ncbi.nlm.nih.gov
Liposomal irinotecan (nal-IRI; Onivyde®; also known as pegylated liposomal irinotecan) has been developed with the aim of maximising ...
Ipsen's Onivyde turns in positive results in pancreatic cancer
https://www.fiercepharma.com
Ipsen's Onivyde proved its worth in previously untreated pancreatic ductal adenocarcinoma, a notoriously tough to treat cancer type.
Onivyde® regimen demonstrated statistically ...
https://www.ipsen.com
Onivyde® regimen demonstrated statistically significant improvement in overall survival in previously untreated metastatic pancreatic ductal ...
Onivyde pegylated liposomal (previously known as Onivyde)
https://www.ema.europa.eu
Onivyde pegylated liposomal is a cancer medicine that is used to treat a form of pancreatic cancer called metastatic adenocarcinoma of the pancreas.